Gladman J R, Dolan G
Department of Health Care of the Elderly, University Hospital, Nottingham, UK.
Postgrad Med J. 1995 Mar;71(833):153-5. doi: 10.1136/pgmj.71.833.153.
We aimed to examine the effect of age upon the control of anticoagulation with warfarin in ordinary clinical practice, using a retrospective examination of routine anticoagulation clinic records from the University Hospital, Nottingham. Considerable over-anticoagulation (international normalisation ratio (INR) > 6.0) during induction occurred in 54 (11%) of 495 patients and was more likely in older patients (p < 0.05). Lesser degrees of over-anticoagulation during induction (INR > 4.0) were also more common in older patients, occurring in 58% of those aged 75 or above. Loading doses of warfarin were not reduced in older patients. INR in the maintenance phase rose with age (p < 0.001) despite lower maintenance doses of warfarin (p < 0.001). An INR > 6.0 in the maintenance phase was noted in 24 (3%) of 739 patients and again was more likely in older patients (p < 0.05). Patients using ambulance transport to the clinic were older than those who did not (p < 0.01) and those aged over 75 had shorter intervals between clinic visits (p < 0.01). We conclude that doctors using warfarin therapy do not take sufficient account of the increased sensitivity of older people to warfarin. Hospital anticoagulant policies need implementation and evaluation.
我们旨在通过回顾诺丁汉大学医院常规抗凝门诊记录,研究年龄对普通临床实践中使用华法林进行抗凝控制的影响。495例患者中有54例(11%)在诱导期出现显著抗凝过度(国际标准化比值(INR)> 6.0),且老年患者更易出现(p < 0.05)。诱导期较低程度的抗凝过度(INR > 4.0)在老年患者中也更常见,75岁及以上患者中有58%出现这种情况。老年患者的华法林负荷剂量未降低。尽管华法林维持剂量较低(p < 0.001),但维持期INR随年龄增长而升高(p < 0.001)。739例患者中有24例(3%)在维持期出现INR > 6.0,同样老年患者更易出现(p < 0.05)。使用救护车前往门诊的患者比未使用的患者年龄更大(p < 0.01),75岁以上患者门诊就诊间隔时间更短(p < 0.01)。我们得出结论,使用华法林治疗的医生没有充分考虑老年人对华法林敏感性增加的问题。医院抗凝政策需要实施和评估。